134 related articles for article (PubMed ID: 12956862)
1. Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia.
Cocito D; Durelli L; Isoardo G
Acta Neurol Scand; 2003 Oct; 108(4):274-80. PubMed ID: 12956862
[TBL] [Abstract][Full Text] [Related]
2. Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody.
Cocito D; Isoardo G; Ciaramitaro P; Migliaretti G; Pipieri A; Barbero P; Cucci A; Durelli L
Muscle Nerve; 2001 Oct; 24(10):1278-82. PubMed ID: 11562906
[TBL] [Abstract][Full Text] [Related]
3. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.
Bromberg MB; Feldman EL; Albers JW
Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342
[TBL] [Abstract][Full Text] [Related]
5. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
[TBL] [Abstract][Full Text] [Related]
6. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy.
Tagawa Y; Yuki N; Hirata K
Muscle Nerve; 2000 Jun; 23(6):895-9. PubMed ID: 10842265
[TBL] [Abstract][Full Text] [Related]
7. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia: a peripheral nerve biopsy study in 18 cases.
Vital A; Lagueny A; Julien J; Ferrer X; Barat M; Hermosilla E; Rouanet-Larrivière M; Henry P; Bredin A; Louiset P; Herbelleau T; Boisseau C; Guiraud-Chaumeil B; Steck A; Vital C
Acta Neuropathol; 2000 Jul; 100(1):63-8. PubMed ID: 10912921
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Brain; 1995 Apr; 118 ( Pt 2)():359-68. PubMed ID: 7735878
[TBL] [Abstract][Full Text] [Related]
10. Polyneuropathy in paraproteinaemia.
Meier C
J Neurol; 1985; 232(4):204-14. PubMed ID: 2995596
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of chronic inflammatory demyelinating polyneuropathy.
Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
[TBL] [Abstract][Full Text] [Related]
12. Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases.
Magy L; Chassande B; Maisonobe T; Bouche P; Vallat JM; Léger JM
Eur J Neurol; 2003 Nov; 10(6):677-85. PubMed ID: 14641513
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients.
Sghirlanzoni A; Solari A; Ciano C; Mariotti C; Fallica E; Pareyson D
Neurol Sci; 2000 Feb; 21(1):31-7. PubMed ID: 10938200
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
Wilson J; Chawla J; Fisher M
J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
[TBL] [Abstract][Full Text] [Related]
15. [Electrophysiological manifestations of chronic inflammatory demyelinating polyradiculoneuropathy].
Vial C; Bouhour F
Rev Neurol (Paris); 2006 Apr; 162(4):522-6. PubMed ID: 16585915
[TBL] [Abstract][Full Text] [Related]
16. Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies.
Lewis RA
Semin Neurol; 2005 Jun; 25(2):217-28. PubMed ID: 15937737
[TBL] [Abstract][Full Text] [Related]
17. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
[TBL] [Abstract][Full Text] [Related]
18. MRI of the brachial plexus in polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Notermans NC; Franssen H; Van Es HW; Ramos LM; Wokke JH; van den Berg LH
Muscle Nerve; 2001 Oct; 24(10):1312-8. PubMed ID: 11562910
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical features of chronic inflammatory demyelinating polyradiculoneuropathy].
Antoine JC
Rev Neurol (Paris); 2006 Apr; 162(4):533-8. PubMed ID: 16585917
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
Gorson KC; Allam G; Ropper AH
Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
